IBA

World leader in particle accelerator technology and key player in the fight against cancer IBA (Ion Beam Applications S.A.)

is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,600 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

19/02/2026

📢 Press release

IBA RadioPharma Solutions and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-and-shreeji-sign-multi-site-agreement-four-cyclotrons-expand-pet-radiopharmaceutical

04/02/2026

🌍🎗️ On World Cancer Day, IBA unites to support everyone whose life has been impacted.

Today, IBA colleagues join the “Cancer turned my world upside down” challenge to show their solidarity. 🤝

As a company committed to advancing cancer care, from diagnosis to treatment, we know how deeply this disease can disrupt lives.

Today and every day, we stand with all those affected. 🧡

02/02/2026

📢 Press release

Last Thursday, IBA Proton Therapy announced it has signed a contract for the supply of a Proteus®ONE proton therapy solution to be installed at the MacKay Memorial Hospital in New Taipei City, Taiwan.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-signs-contract-proteusrone-proton-therapy-system-be-located-mackay-memorial-hospital-new-taipei

05/01/2026

Starting the year with good news!

In late December, IBA Proton Therapy announced it has signed a contract with The Catholic University of Korea, Seoul St.Mary's Hospital, one of the largest hospital in South Korea, for a Proteus®PLUS solution.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-signs-contract-three-room-proteusrplus-solution-be-installed-seoul-st-marys-hospital

19/12/2025

📢 Press release

IBA acquires ORA, expanding its strategic leadership in Nuclear Medicine.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-acquires-ora-expanding-its-strategic-leadership-nuclear-medicine

18/12/2025

15/12/2025

📢 Press release

IBA Proton Therapy shares that, The Lancet – one of the world’s most renowned academic journals – published a landmark study that recommends proton therapy as a new standard of care for patients with oropharyngeal cancer.

🔗 Read the full press release here: https://www.iba-worldwide.com/proton-therapy-new-standard-care-patients-oropharyngeal-cancer

11/12/2025

📢 Press release

IBA Industrial Solutions signs a contract with China Gold Irradiation to install a Rhodotron® in Zhejiang, expanding sustainable X-ray irradiation capacity in China.

🔗 Read the full press release here: https://www.iba-worldwide.com/china-gold-irradiation-introduces-ibas-sustainable-x-ray-irradiation-technology-expand-its

09/12/2025

📢 Press release

IBA signs a contract with YAS Healthcare for a Proteus®ONE solution, the first proton therapy system to be installed in Dubai, UAE.

🔗 Read the full press release here: https://www.iba-worldwide.com/yas-healthcare-signs-contract-proteusrone-solution-first-proton-therapy-system-be-installed-dubai

12/11/2025

🎉 A new chapter begins in Asia

IBA has inaugurated its new Asia headquarters in Beijing, China, a key milestone in expanding its presence across the Asia-Pacific region.

This strategic move strengthens IBA’s position in China and supports innovation in the high-end manufacturing and cancer care across Asia.

05/11/2025

At IBA, we believe science is for everyone. 🔬

Last month, IBA opened its doors to 25 secondary school girls. They discovered careers in science and technology alongside our female engineers.

🧬Every talent can shape the science of tomorrow. Explore careers at IBA and connect with a vibrant community of talented women: https://careers.iba-worldwide.com/

03/11/2025

📢 Press release

IBA announces the acquisition of PhantomX GmbH to integrate Artificial Intelligence Quality Assurance into its dosimetry solutions and expand its portfolio in healthcare diagnostics and therapeutic systems.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-integrates-artificial-intelligence-quality-assurance-dosimetry-solutions-through-acquisition

Adres

Louvain-la-Neuve

Website

http://www.iba-worldwide.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer IBA nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.